http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8705020-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dafb5bbc2ec47ebcb7becbbe60f704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
filingDate 1987-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03abb287579e8e1f9f21b51ccb4d39ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc6768be1e7004c478ae8f85cacb465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6c19666ce2d6e2fc90d5ec3b709ff31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade53f44a96b47e79effc30fbffe9052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5ed077829fc6ec2a7ddae92b565e3c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63aa819920801229adad13a441c57e37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b6282e0f11f27090bf6b6ff35076dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_779638e10c201dfbf889464cf42bf94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_366159ca246cc7891a22c56a6de872a3
publicationDate 1987-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8705020-A1
titleOfInvention 3,4-dihydro-2h-benzopyran derivatives and their medicinal use
abstract 3,4-Dihydro-2H-benzopyran derivatives represented by general formula (I), (wherein n represents an integer of 0, 2 or 3, R represents a nitrogen-containing heterocyclic group selected from among (II), R1 and R2 each represents a hydrogen atom or an optionally substituted alkyl, aralkyl, arylalkenyl, aryl or acyl group, and R3 represents a hydrogen atom or an alkyl group) and pharmacologically acceptable salts thereof. These compounds have an activity of inhibiting 5-lipoxigenase, anti-allergic effect, anti-histaminic effect, effect of preventing peroxidation of lipid, effect of inhibiting platelet agglutination, ect. and are useful as drugs for treating bronchial asthma, allergic disease, immune disease, inflammatory disease, Psoriasis vulgaris, brain blood trouble, ischemic disease, thrombosis, etc. Use of the compounds as drugs is also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7553837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5260294-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005012293-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7514461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-697050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0487510-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8044097-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0640609-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5750544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1100774-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096362-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5489593-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5534536-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0533579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7875607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9515958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7470798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0354508-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0354508-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6596745-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096362-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0364274-A1
priorityDate 1986-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129551097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136319

Total number of triples: 55.